Skip to content
MarketScale
‹ Back to IndustriesHealthcare

COVID-19 and the Concerns of the Healthcare Professional

On this episode of I Don’t Care with Kevin Stevenson, Stevenson goes big picture, sourcing insights from his vast network of healthcare professionals to determine the industry’s biggest concerns related to COVID-19 and the world’s slow move toward a new normal in the wake of the pandemic. Stevenson condensed those thoughts into five central concerns…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

On this episode of I Don’t Care with Kevin Stevenson, Stevenson goes big picture, sourcing insights from his vast network of healthcare professionals to determine the industry’s biggest concerns related to COVID-19 and the world’s slow move toward a new normal in the wake of the pandemic.

Stevenson condensed those thoughts into five central concerns of healthcare workers:

Their Jobs

Many hospitals and other healthcare operations have furloughed or laid off staff, particularly due to lost revenue tied to elective procedures and more, and a continuation of the pandemic could lead to more cuts.

The Overall Economy

Healthcare and industry workers are by no means immune to the overall economic downturn caused by the pandemic, which has led to a decrease in insured patients, etc.

Safety in the Workplace

Like many, healthcare workers are generally concerned about contracting COVID-19 in the workplace, though hospitals and other facilities are perhaps the safest place to be due to precautions in place.

A Lack of Personal Protective Equipment

PPE, such as masks, gowns, gloves, face shields and more, are still hard to acquire for many healthcare operations, particularly smaller and more rural ones.

The Potential for a Vaccine Not Being Created

For many, a vaccine is the only true “end” in sight to the COVID-19 pandemic. While some are concerned that a vaccine may not be possible, Stevenson said he believes one will be created by the massive amount of effort being put forth to expedite one’s creation.

To hear all of Stevenson’s thoughts on these current concerns and the overall trends in healthcare at the moment, listen to the entire episode.

Catch up on previous episodes of I Don’t Care with Kevin Stevenson!

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512